MAP2 and Alzheimer disease: When the AD-tau preparations were used at the concentration of 1 μg tau/106 cells, there was no sign of neurotoxicity based on the morphology of the neuronal perikarya and their processes revealed by MAP2 staining (Fig. 1c).